NCT00700297View on ClinicalTrials.gov

Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

169

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

October 31, 2005

Study Completion Date

May 31, 2006

Conditions
Behcet's Syndrome
Interventions
DRUG

Colchicine

100 mg Colchicine per day for 4 months

DRUG

Placebo

One tablet placebo per day for 4 months

Trial Locations (1)

14114

Rheumatology research Center, Tehran UMS, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT00700297 - Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease | Biotech Hunter | Biotech Hunter